SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Savient Pharmaceuticals, Inc. Announces Multiple Abstracts Related to KRYSTEXXA® in the Treatment of Refractory Chronic Gout to be Presented at the 2012 ACR/ARHP Annual Meeting